John E Creange

Title: John E. Creange: Innovator in Pituitary-Adrenal Function Suppression

Introduction

John E. Creange is a notable inventor based in Kinderhook, NY (US). He has made significant contributions to the field of medical science, particularly in the area of pituitary-adrenal function suppression. His innovative approach has led to the development of a unique method that has potential implications for medical treatments.

Latest Patents

John E. Creange holds a patent for a method titled "Pituitary-adrenal inhibiting method." This patent describes a technique for suppressing pituitary-adrenal function without producing peripheral glucocorticoid effects in primates. The method involves administering an effective amount of (17.alpha.)-2'-(4-fluorophenyl)-2'H-pregna-2,4-dien-20-yno[3,2-c]-pyrazol-17-ol to reduce the concentration of circulating hydrocortisone.

Career Highlights

Throughout his career, John E. Creange has worked with Sterling Drug Inc., where he has been able to apply his innovative ideas in a practical setting. His work has contributed to advancements in pharmacology and therapeutic methods.

Collaborations

John has collaborated with several professionals in his field, including Harry P. Schane, Jr. and Homer R. Harding. These collaborations have likely enriched his research and development efforts, leading to more robust innovations.

Conclusion

John E. Creange's contributions to the field of medical science through his patent on pituitary-adrenal function suppression highlight his role as an innovator. His work continues to influence the development of therapeutic methods in medicine.